TPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37%...

|About: Par Pharmaceutical Compan... (PRX)|By:, SA News Editor

TPG agrees to acquire Par Pharmaceutical (PRX) for $1.9B, or $50/share, which represents a 37% premium over Par's closing price on Friday. Shares +36% premarket. (PR)